Target intelligence / Profile preview

Cationic surfactant-induced membrane disruption

Molecular classification
Other (mechanism of action, not a molecular family, not a receptor, enzyme, or transporter)
01

Overview

Cationic surfactant-induced membrane disruption is a mechanism of cell membrane damage whereby surfactants with positive charges interact with negatively charged lipid components of cellular (often bacterial) membranes. The disruption occurs via electrostatic and hydrophobic interactions: the polar (cationic) head groups bind to negatively charged lipid head groups, and the hydrophobic alkyl chains embed into the lipid bilayer. This process alters membrane structure, increases permeability, and can ultimately cause cell lysis. This mechanism is widely exploited in disinfection, antimicrobial therapy, and design of nanocarriers for drug delivery, but also poses risks of cytotoxicity and environmental harm[1][2][5][6][7][8][9].

Other names
Cationic surfactant membrane permeabilizationmembrane lysis by cationic surfactantscationic amphiphile-induced membrane disruption
02

Mechanism of action

Electrostatic attraction of cationic surfactant to negatively charged lipid head groups. Integration of surfactant hydrophobic tails into the membrane bilayer. Disruption of membrane structure, leading to increased permeability, deformation, rupture, and leakage of cytoplasmic contents.

03

Biological functions

Membrane permeabilizationCell lysisAntimicrobial activityFacilitation of cellular uptake (in nanomedicine/drug delivery)
04

Disease associations

Infection control (antibacterial, antifungal)Drug delivery (nanocarriers)May contribute to toxicity or unwanted cell death in non-target tissues
05

Safety considerations

Cytotoxicity to eukaryotic (human) cells at high concentrationsHemolytic activity (can damage red blood cells)Development of microbial resistanceEnvironmental toxicity and bioaccumulation potential
06

Interacting drugs

Benzalkonium chloride (BAC)

6 more in the full profile.

07

Biomarkers

None established for patient selection; efficacy can sometimes be monitored by markers of membrane integrity, cytoplasmic leakage, or cell viability in microbiological assays

Beyond the preview

Go deeper on Cationic surfactant-induced membrane disruption.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cationic surfactant-induced membrane disruption.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call